The Neurotherapeutics Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Neurotherapeutics Market is estimated to be $ 5900 USD Million in 2016 and predicted to rise to $ 7,602 USD Million by the end of 2021 with a CAGR of 5.2 %. The market is segmented on the basis of treatment into Neurologic drugs And Neurologic Devices. Neurologic drugs are further classified into oral administration, injections and others. Neurologic Devices are categorized into Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS), transcranial magnetic stimulation, Deep Brain Stimulator, and others. On the basis of disorders, the market is segmented into Central Nervous system (CNS) disorders, Peripheral Nervous system (PNS) disorders, Autonomous Nervous system (ANS) disorders. On the basis of Distribution channels, the market is segmented into Hospitals, Neurotherapeutic center, Clinical research organizations, Clinics. Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
The market is primarily driven by factors such as growing geriatric population, increasing R&D expenditure, increasing Health care expenditute, a better understanding of the nature of neurologic diseases. Lack of awareness in some developing nations, lack of proper reimbursement policies, and restrictions by regulatory bodies are the restraints that are hindering the growth of the dental device market.
North America is projected to account the highest share in the market due to due to the presence of top market players and also major technological advancements, government initiatives, heightened awareness about neurological conditions. Asia-Pacific is expected to show the highest CAGR during the forecast period due to strong economic growth in developing countries such as India, China, and Malaysia.
Major players that are influencing Global Neurotherapeutics Market are Abbott Laboratories, Inc., Becton, Novartis AG, Dickinson and Company, Pfizer, Inc., Johnson & Johnson, Biogen, Inc., GlaxoSmithKline, Inc., AstraZeneca plc, Sanofi-Aventis, Spiegelberg, stryker, Covidien, Medtronic, GE healthcare, and Merck & Co.
Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-neurotherapeutics-market-1270/” and checkout our recent reports in the Therapeutics category at “http://www.marketdataforecast.com/research-reports/healthcare/therapeutics-11/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.